Literature DB >> 16584185

Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae.

Stefania Galdiero1, Mariateresa Vitiello, Pietro Amodeo, Marina D'Isanto, Marco Cantisani, Carlo Pedone, Massimiliano Galdiero.   

Abstract

Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in young children, characterized by inflammation mainly mediated by cytokines and chemokines. One of the most abundant components of the Hib outer membrane is the P2 porin, which has been shown to induce the release of several inflammatory cytokines. Synthetic peptides corresponding to loops L5, L6, and L7 activate JNK and p38 mitogen-activated protein kinase (MAPK) pathways, L7 being the most active peptide. Therefore, sequence-activity relationships and key residues were identified by elongating sequence to different extents, designing cyclic peptides, and performing an alanine scan of L7. The ability of mutant peptides to induce activation of signal transduction pathways and release of TNF-alpha and IL-6 has been determined, and, in conjunction with CD spectra, bioinformatics analysis, and molecular dynamics data, showed that 6 out of 8 amino acids contribute significantly to the overall activity. Molecular dynamics showed that L7 modifications increased loop rigidity and helicity after Gly6 mutation, thus, providing a possible structural explanation for observed loss of bioactivity. This work provides insights into essential molecular details of P2 that may impact on the pathogenesis of Hib infections where interruption of the signaling cascade could represent an attractive therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584185     DOI: 10.1021/bi052262p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Porin isolated from the outer membrane of Erwinia amylovora and its encoding gene.

Authors:  M Elazar; D Halfon; I Pechatnikov; Y Nitzan
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

2.  Cigarette smoke inhibits airway epithelial cell innate immune responses to bacteria.

Authors:  Ritwij Kulkarni; Ryan Rampersaud; Jorge L Aguilar; Tara M Randis; James L Kreindler; Adam J Ratner
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

3.  Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity.

Authors:  Marco Cantisani; Mariateresa Vitiello; Annarita Falanga; Emiliana Finamore; Marilena Galdiero; Stefania Galdiero
Journal:  Int J Nanomedicine       Date:  2012-05-11

4.  Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.

Authors:  Elena V Efimova; Hua Liang; Sean P Pitroda; Edwardine Labay; Thomas E Darga; Vera Levina; Anna Lokshin; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Int J Radiat Biol       Date:  2009-05       Impact factor: 2.694

5.  Mapping the laminin receptor binding domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2.

Authors:  Noha M Abouseada; Mahde Saleh A Assafi; Jafar Mahdavi; Neil J Oldfield; Lee M Wheldon; Karl G Wooldridge; Dlawer A A Ala'Aldeen
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

Review 6.  Microbe-host interactions: structure and role of Gram-negative bacterial porins.

Authors:  Stefania Galdiero; Annarita Falanga; Marco Cantisani; Rossella Tarallo; Maria Elena Della Pepa; Virginia D'Oriano; Massimiliano Galdiero
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

7.  Surface-exposed loops L7 and L8 of Haemophilus (Glaesserella) parasuis OmpP2 contribute to the expression of proinflammatory cytokines in porcine alveolar macrophages.

Authors:  Ye Zhou; Saixiang Feng; Xinyi He; Qun Zhou; Yuanwei Wang; Hua Yue; Cheng Tang; Bin Zhang
Journal:  Vet Res       Date:  2019-11-29       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.